Fund aids students' college dreams Sixteen Hunterdon County high school seniors recently were awarded $79,000 in college aid by the Jennie M.Haver Memorial Scholarship Fund, and one student is getting the largest-ever award given in the fund's history.
In its 52 years,...
Looking for answers to an incurable disease There's no shortage of charity golf outings that do incredible things within communities and make a difference in people's lives with the money raised.And some of them can get pretty emotional.
It's impossible not to shed a tear during...
Indian Generic Drug Companies, HIV/AIDS Advocacy Group File Opposition to Patent of Roche's Antiretroviral Val Indian generic pharmaceutical companies Cipla and Matrix Laboratories and the HIV/AIDS advocacy group Delhi Network of Positive People, or DNP+, recently filed an objection to an Indian patent office's decision to give a patent to Roche's...
30 June 2008, London ... ValiRx (AIM: VAL), the cancer therapeutics and diagnostics company, today announces i (ValiRx or the Company) Audited Results For The 12 Month Period Ended 31 December 2007 HIGHLIGHTS Operations Successful in vitro studies completed on GeneICE therapeutics platform GeneICE patents granted in Europe and the USA Creation of...
Hospital campaigner Val Compton survives High Court Appeal THREE appeal judges have decided to overturn an appeal by Wiltshire PCT that would have effectively ended hospital campaigner Val Compton's legal battle to save services at Marlborough's hospital.The primary care trust appealed...
Drug delivery to the inner ear and methods of using same Pharmaceutical Patents Title: United States Patent: 7,387,614 Issued: June 17, 2008 Staecker; Hinrich (Reisterstown, MD) University of Maryland, Baltimore (Baltimore, MD) Appl.No.: July 21, 2004 -- Pharm/Biotech/etc.
The inventors have...
Sanofi Pasteur Inaugurates High Tech Vaccine Production Facility To Respond To Soaring Demand Worldwide Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced recently the inauguration of a high-tech vaccine production facility in France to respond to soaring demand worldwide.This new 100 million euros facility located in ...
ADHD Gene Doesn't Predict Response to Drugs WEDNESDAY, June 25 (HealthDay News) -- Canadian researchers report that a gene variant that seems to affect the severity of attention-deficit hyperactivity disorder did not help them predict which patients are likely to respond to a class of...
ValiRx Announces Final Results for 12 Month Period Ended 31 December 2007 ValiRx (AIM: VAL), the cancer therapeutics and diagnostics company, today announces its final results for the twelve month period ended 31 December 2007.HIGHLIGHTS Operations Successful in vitro studies completed on GeneICE...
Sanofi Pasteur Inaugurates High Tech Vaccine Production Facility to Respond to Soaring Demand Worldwide - New 100 million euros facility incorporates latest technology to produce vaccines meeting the highest quality standards - Sanofi Pasteurs commitment to global health is exemplified by significant investments in vaccine production...
Promising In Vivo Data for VAL 101 Compound Targets Pancreatic Cancer, based on GeneICE Gene Silencing Technol ValiRx plc (AIM:VAL, 'ValiRx'), the cancer therapeutics and diagnostics company, has announced promising in vivo results for its lead molecule VAL 101 which uses its gene silencing technology GeneICE(tm) in preclinical xenograph models...
Sanofi launches $6.25bn vaccine battle plan GET THE LATEST MARKET REPORTS All market reports 26-Jun-2008 - Sanofi-Aventis is to invest $6.25bn into vaccine production between now and 2015 as the company attempts to keep pace with rising demand.This sizeable investment is in...
Sanofi Pasteur Inaugurates High Tech Vaccine Production Facility to Respond to Soaring Demand Worldwide (PR Newswire Europe via COMTEX) ----New 100 Million Euros Facility Incorporates Latest Technology to Produce Vaccines Meeting the Highest Quality Standards VAL DE REUIL, France, June 25 /PRNewswire/ -- Sanofi Pasteur, the vaccines...
Results from ValiRx in the Epigenetics Field Announced Below - ValiRx plc (AIM:VAL, 'ValiRx'), the cancer therapeutics and diagnostics company, has announced promising in vivo results for its lead molecule VAL 101 which uses its gene silencing technology GeneICE(TM) in preclinical xenograph...
Recreation/Tennis Results Marc Adams (M) def.Gary Ribchinsky 6-0, 6-2; Peter Harrow (OS) def.
Win La 6-0, 6-3; Andy Rock/Archie Tracy (OS) def.
Peter Yednerowicz/Dana Lord 6-4, 7-5; Russ Brown/Steve Dix (OS) def.
Dick Hartnett/Forrest Skylar, 6-4, 6-2.
ADHD Gene Doesn't Predict Response to Drugs WEDNESDAY, June 25 (HealthDay News) Canadian researchers report that a gene variant that seems to affect the severity of did not help them predict which patients are likely to respond to a class of drugs widely used to treat the disorder.
'Bounce back' says breast cancer group Support for women with breastcancer in and around Leamington is now on hand in the form of a new group called Bounce Back.When Sam Kneeshaw, 43, and 49-year-old Kath Bannister were diagnosed with breast cancer, they felt the need to talk...
Sanofi Launches High Tech Vaccine Facility Sanofi Pasteur,the vaccines unit of Sanofi-Aventis, has established a new automated vaccine production facility in Val de Reuil, France to respond to increased vaccine demand worldwide.This new $156 million facility incorporates the...
COMMUNIQUE: PR Newswire: Sanofi Pasteur Inaugurates High Tech Vaccine Production Facility to Respond to Soarin - New 100 Million Euros Facility Incorporates Latest Technology to Produce Vaccines Meeting the Highest Quality Standards VAL DE REUIL, France, June 25 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group,...
Sanofi Pasteur Inaugurates High Tech Vaccine Production Facility to Respond to Soaring Demand Worldwide - New 100 Million Euros Facility Incorporates Latest Technology to Produce Vaccines Meeting the Highest Quality Standards VAL DE REUIL, France, June 25 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group,...
ADHD Gene Doesn't Predict Response to Drugs WEDNESDAY, June 25 (HealthDay News) -- Canadian researchers report that their discovery of a gene variant that seems to affect the severity of attention-deficit hyperactivity disorder did not help them predict which patients are likely to...
Sanofi Pasteur Inaugurates High Tech Vaccine Production Facility to Respond to Soaring Demand Worldwide VAL DE REUIL, France, June 25 /PRNewswire/ -- - New 100 Million Euros Facility Incorporates Latest Technology to Produce Vaccines Meeting the Highest Quality Standards VAL DE REUIL, France, June 25 /PRNewswire/ -- Sanofi Pasteur,...
Promising In Vivo Data for VAL 101 Compound - targets Pancreatic Cancer, based on GeneICE™ Gene Silencin London ..ValiRx plc (AIM:VAL, ValiRx), the cancer therapeutics and diagnostics company, has announced promising in vivo results for its lead molecule VAL 101 which uses its gene silencing technology GeneICE in preclinical xenograph...
Sanofi launches $6.25bn vaccine battle plan GET THE LATEST MARKET REPORTS All market reports 26-Jun-2008 - Sanofi-Aventis is to invest $6.25bn into vaccine production between now and 2015 as the company attempts to keep pace with rising demand.This sizeable investment is in...
Sanofi Pasteur Inaugurates High Tech Vaccine Production Facility to Respond to Soaring Demand Worldwide VAL DE REUIL, France, June 25 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today the inauguration of a high-tech vaccine production facility in France to respond to soaring demand worldwide....
